Beijing StarMab Biomed Technology Ltd
2 clinical trials · Sponsor
◉ Watch Beijing StarMab Biomed Technology Ltd
| Record | Firm | Date |
|---|---|---|
| Phase I Study of SM2275 Injection in Patients With Advanced Solid Tumors (NCT07750132) | Beijing StarMab Biomed Technology Ltd | 2026-08-01 |
| Clinical Study of SM3321 With Solid Tumors (NCT06087770) | Beijing StarMab Biomed Technology Ltd | 2023-12-07 |
Track Beijing StarMab Biomed Technology Ltd automatically
Every clearance here is in the API, with alerts when new ones post.